CYP19A1 and breast cancer: On the other hand, the low intratumoral expression of the CYP19A1 gene significantly influenced the increase in locoregional recurrence rate in patients with premenopausal breast cancer (31), in agreement with studies in the literature showing decreased levels of CYP19A1 gene expression in premenopausal women (39,51).